Monday, June 22, 2009 8:46:23 AM
Drug/indication: ipilimumab for metastatic melanoma
Clinical trial event: phase III top-line results
Timing: end of 2009
More from Adam Feuerstein Biotech Stock Mailbag: Gleaming the CubistOculus Sidesteps FDA Rules With Wound CleanerCell Therapeutics: Deadline Nears for Debt Tender OfferVirus Forces Genzyme to Shut PlantNew RA Data Could Be Magic Pill for RigelBiotech Stock Mailbag: Good Stocks ExistHemispherx, in FDA Limbo, Seeks More CashBiotech Calendar: Key Clinical Trial DatesMicromet Cancer Drug Meets Goal; Shares RiseVanda Ripe for Picking, or Dead on the Vine? Market Activity Celgene Corporation| CELG UPGTX Incorporated| GTXI DOWNThe phase III study enrolls patients with previously untreated metastatic melanoma and treats them with a combination of ipilimumab plus the chemotherapy dacarbazine or dacarbazine plus placebo.
http://www.thestreet.com/story/10515986/3/biotech-calendar-more-key-clinical-trial-dates.html
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM